Disseminated Darier Disease: What to Do When Oral Retinoids Have Not Achieved Clinical Improvement
Clinical Scenario
This protocol is for patients with disseminated (generalized, not localized) Darier disease — widespread skin involvement — in whom a prior course of oral retinoid therapy has not led to the expected clinical improvement. Oral retinoids are recognised as the most effective oral option for generalized Darier disease; when adequate response is not achieved, a structured next-step approach is required.
Previous Treatment — Escalation Trigger
The preceding line used oral retinoids (etretinate, acitretin, or isotretinoin). This protocol applies when clinical improvement of skin lesions is not achieved within 1 to 4 weeks of that treatment.
Treatment Approach — Partial Overview
Following retinoid failure in disseminated disease, the regimen draws on alternative systemic agents from different pharmacological classes — including antibiotic-class and immunomodulatory options — with the clinical goal of reducing itching and improving skin lesion severity and skin fragility. The complete evidence-based regimen, agent selection criteria, and full clinical pathway are available via the link below.
Full protocol details are not shown here.
References
- DOI: 10.25259/IJDVL_963_19
- Oral retinoids were the most effective oral therapy and were prescribed in the cases of generalized Darier disease.
- Commonly used for treatment of acne, doxycycline 100 mg/day was recently used in the treatment of Darier disease and was found to have positive outcome in 2 female patients without any reported side effects.
- Cyclosporine 3 mg/kg/day was found to be helpful in treating 2 middle‑aged male patients with widespread eczematized Darier disease.
View source ↗